
Fulgent Genetics, Inc.
Nasdaq · Services-Medical Laboratories
Company Overview
A concise company profile alongside the latest public filing activity.
Fulgent Genetics operates a molecular diagnostics laboratory that provides genetic and genomic testing services, including oncology, reproductive health, and infectious disease testing, using next-generation sequencing technology.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Xie JianPresident and COO | Sell | $42K | 2,127at $19.66 | Sep 2, 2026 |
| Gao HanlinChief Scientific Officer | Sell | $33K | 1,673at $19.66 | Sep 2, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable FLGT activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.